tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

TSVT Stock Latest News

2seventy bio Strikes Strategic Gene Therapy Deal with Novo Nordisk
Company Announcements2seventy bio Strikes Strategic Gene Therapy Deal with Novo Nordisk
1M ago
8K
TSVT
2seventy Bio announces sale of Hemophilia A candidate for up to $40M
PremiumThe Fly
2seventy Bio announces sale of Hemophilia A candidate for up to $40M
1M ago
BMY
NVO
2seventy bio’s Board Elections and Financial Oversight Update
PremiumCompany Announcements
2seventy bio’s Board Elections and Financial Oversight Update
2M ago
8K
TSVT
2seventy Bio downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
2seventy Bio downgraded to Sell from Neutral at Goldman Sachs
2M ago
TSVT
2seventy Bio price target lowered to $11 from $12 at Canaccord
PremiumThe Fly
2seventy Bio price target lowered to $11 from $12 at Canaccord
3M ago
TSVT
2seventy Bio shares will remain range-bound, says Guggenheim
PremiumThe Fly2seventy Bio shares will remain range-bound, says Guggenheim
3M ago
TSVT
2seventy Bio reports Q1 EPS ($1.01), consensus( 81c)
PremiumThe Fly
2seventy Bio reports Q1 EPS ($1.01), consensus( 81c)
3M ago
TSVT
2seventy Bio price target raised to $12 from $9 at Citi
PremiumThe Fly
2seventy Bio price target raised to $12 from $9 at Citi
4M ago
TSVT
2seventy bio’s Abecma Wins FDA Approval for Multiple Myeloma
PremiumCompany Announcements
2seventy bio’s Abecma Wins FDA Approval for Multiple Myeloma
4M ago
8K
TSVT
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
PremiumThe Fly
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
4M ago
BMY
TSVT
Fly Insider: 2seventy bio, Coinbase among week’s notable insider trades
PremiumThe Fly
Fly Insider: 2seventy bio, Coinbase among week’s notable insider trades
4M ago
GO
ABNB
2seventy bio Finalizes Asset Sale and Executive Transition
PremiumCompany Announcements
2seventy bio Finalizes Asset Sale and Executive Transition
4M ago
8K
TSVT
2seventy bio Reinforces Board, Faces Engine Capital Nominations
PremiumCompany Announcements2seventy bio Reinforces Board, Faces Engine Capital Nominations
4M ago
8K
TSVT
2seventy bio CSO Exits, Abecma Advances with FDA Committee
PremiumCompany Announcements
2seventy bio CSO Exits, Abecma Advances with FDA Committee
4M ago
8K
TSVT
2seventy bio trading resumes
PremiumThe Fly
2seventy bio trading resumes
5M ago
TSVT
Bristol Myers, 2seventy Bio: FDA’s ODAC votes in favor of Abecma
PremiumThe Fly
Bristol Myers, 2seventy Bio: FDA’s ODAC votes in favor of Abecma
5M ago
BMY
TSVT
2seventy bio trading halted, news pending
PremiumThe Fly
2seventy bio trading halted, news pending
5M ago
TSVT
2seventy Bio price target lowered to $12 from $20 at Canaccord
PremiumThe Fly
2seventy Bio price target lowered to $12 from $20 at Canaccord
5M ago
TSVT
2seventy Bio: Abecma generated $56M U.S. commercial revenue in Q4
PremiumThe Fly
2seventy Bio: Abecma generated $56M U.S. commercial revenue in Q4
5M ago
BMY
TSVT
2seventy bio: Close of asset sale to Regeneron seen in 1H24
PremiumThe Fly2seventy bio: Close of asset sale to Regeneron seen in 1H24
5M ago
REGN
TSVT
2seventy Bio reports Q4 EPS ($1.11), consensus (99c)
PremiumThe Fly
2seventy Bio reports Q4 EPS ($1.11), consensus (99c)
5M ago
TSVT
2Seventy Bio, Inc. (TSVT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
2Seventy Bio, Inc. (TSVT) Q4 Earnings Cheat Sheet
5M ago
TSVT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >